National Pharmaceutical Regulatory Agency (NPRA) of Malaysia published an updated version of the Guidelines for the Implementation of Drug Information Leaflets for Consumers (RiMUP), effective from 01 April 2025.

Digital Submission via QUEST3+: Starting April 2025, all RiMUPs for evaluation by the Pharmacovigilance Section (PKKK) must be submitted through the QUEST3+ system, replacing manual submissions

With our Ikyzen system, you will benefit from continuously updated information that reflects changes in regulatory frameworks across various nations.